Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival

Introduction: Non-small-cell lung cancer is still diagnosed at an inoperable stage and systematic treatment is the only option. Immunotherapy is currently considered to be the tip of the arrow as the first-line treatment for patients with a programmed death-ligand 1 ≥ 50. Sleep is known to be an ess...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Petridis, Dimitrios, Kosmidis, Christoforos, Sapalidis, Konstantinos, Nena, Lila, Matthaios, Dimitris, Papadopoulos, Vasilis, Perdikouri, Eleni Isidora, Porpodis, Konstantinos, Kakavelas, Paschalis, Steiropoulos, Paschalis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944906/
https://www.ncbi.nlm.nih.gov/pubmed/36810540
http://dx.doi.org/10.3390/diseases11010026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944906/
https://www.ncbi.nlm.nih.gov/pubmed/36810540
http://dx.doi.org/10.3390/diseases11010026

Ejemplares similares